Related Experiment Video

Updated: May 24, 2026

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

Impacts of nanoparticles on cardiovascular diseases: modulating metabolism and function of endothelial cells

Jie Meng1, Xian-da Yang, Lee Jia

  • 1Key Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, Beijing 100190, China. mengj@nanoctr.cn

Current Drug Metabolism
|March 3, 2012
PubMed

Insights

This review explores how nanoparticles affect endothelial cells, crucial for blood vessel health and cardiovascular disease (CVD) progression. It analyzes nanoparticle impacts and potential therapeutic uses for CVD.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Biology
  • Nanotechnology

Background:

  • Endothelial cells regulate vital molecule and nutrient exchange.
  • Endothelial cell dysfunction is central to cardiovascular diseases (CVD) like atherosclerosis.
  • Nanotechnology offers new avenues for understanding and treating CVD.

Purpose of the Study:

  • To review endothelial cell biology.
  • To evaluate nanoparticle effects on endothelial cell behavior and function.
  • To discuss nanoparticle applications in CVD treatment.

Main Methods:

  • Literature review of endothelial cell biology.
  • Analysis of studies on nanoparticle interactions with endothelial cells.
  • Evaluation of nanoparticle properties and their CVD treatment potential.

Main Results:

  • Nanoparticles significantly impact endothelial cell functions.
  • Different nanoparticles exhibit varied effects, advantages, and disadvantages.
  • Potential for targeted nanoparticle-based CVD therapies exists.

Conclusions:

  • Understanding nanoparticle-endothelial cell interactions is key for CVD management.
  • Careful selection of nanoparticles is crucial for therapeutic efficacy.
  • Nanoparticles hold promise for future cardiovascular disease treatments.

More Related Videos

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow07:00

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

Published on: March 14, 2021

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...